Pyrazolopyrimidine fused thiazolidinone hybrids as CDK2 inhibitors: insights from pharmacophore modeling, docking, DFT and molecular dynamics simulations

Bharath Kumar Chagaleti, Venkatesan Saravanan, Ali Oubella, Saad H. Alotaibi, Ali Altharawi, Kathiravan MK

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pyrazolopyrimidine fused thiazolidinone hybrids as CDK2 inhibitors: insights from pharmacophore modeling, docking, DFT and molecular dynamics simulations'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology